Cargando…
三级淋巴结构在非小细胞肺癌预后及免疫治疗中的研究进展
Lung cancer is the leading cause of cancer death, and non-small cell lung cancer (NSCLC) accounts for 85%. Immunotherapy has significantly improved the clinical prognosis of patients with NSCLC. However, because of the complexity and heterogeneousness of the tumor microenvironment, only a subset of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558765/ https://www.ncbi.nlm.nih.gov/pubmed/37752541 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.23 |